# Effect of Classic Secondary Prevention in Type 2 MI: A Target Trial Emulation Study

> **NCT06736353** · — · COMPLETED · sponsor: **Uppsala University** · enrollment: 14000 (actual)

## Conditions studied

- Myocardial Infarction Type 2

## Interventions

- **DRUG:** Beta Blocker Therapy or No Therapy (Control)
- **DRUG:** RAAS blocker Therapy or No therapy (Control)
- **DRUG:** Statin Therapy or No Therapy (Control)
- **DRUG:** Single Antiplatelet Therapy or No Therapy (Control)
- **DRUG:** Dual Antiplatelet Therapy or No Therapy (Control)

## Key facts

- **NCT ID:** NCT06736353
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09-03
- **Primary completion:** 2022-05-05
- **Final completion:** 2022-05-05
- **Target enrollment:** 14000 (ACTUAL)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06736353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06736353, "Effect of Classic Secondary Prevention in Type 2 MI: A Target Trial Emulation Study". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT06736353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*